Literature DB >> 21054524

Impact of amino acid substitutions in hepatitis C virus genotype 1b core region on liver steatosis and glucose tolerance in non-cirrhotic patients without overt diabetes.

Yoshio Sumida1, Kazuyuki Kanemasa, Tasuku Hara, Yutaka Inada, Kyoko Sakai, Shunsuke Imai, Naohisa Yoshida, Kohichiroh Yasui, Yoshito Itoh, Takeshi Okanoue, Toshikazu Yoshikawa.   

Abstract

BACKGROUND AND AIM: The hepatitis C virus (HCV) core protein induces hepatic steatosis and glucose intolerance in transgenic mice. The aim of this study was to clarify the impact of mutations in the HCV core region on hepatic steatosis and glucose tolerance in patients with chronic hepatitis C.
METHODS: Seventy-four Japanese patients (27 men, 47 women; mean age, 61.9 years) infected with HCV 1b with high viral load (>5 log IU/ml), without cirrhosis and overt diabetes, were enrolled. Substitutions in amino acids 70 and 91 of the HCV genotype 1b core region, the percentage of hepatic steatosis by liver histology, and glucose tolerance evaluated by the oral glucose tolerance test were investigated in all patients.
RESULTS: Steatosis was observed in 40 patients (54%). Transaminase activities, γ-glutamyl-transpeptidase, serum ferritin levels, homeostasis model assessment of insulin resistance index, and substitutions of amino acid 70 were significantly associated with the presence of steatosis, upon univariate analysis. Glucose intolerance was more prevalent in patients with steatosis (63%) than in those without steatosis (32%, P = 0.012). Multivariate analysis showed that substitution of amino acid 70 (odds ratio: 4.924; 95% confidence interval: 1.442-16.815; P = 0.014) and glucose intolerance (odds ratio: 3.369; 95% confidence interval: 1.076-10.544; P = 0.040) were independent factors related to liver steatosis. Levels of plasma glucose and serum insulin after glucose load were similar between patients with and without substitutions of amino acids 70 and 91.
CONCLUSIONS: Amino acid substitutions in the HCV genotype 1b core region are associated with hepatic steatosis in patients with chronic hepatitis C, independent of glucose intolerance.
© 2011 Journal of Gastroenterology and Hepatology Foundation and Blackwell Publishing Asia Pty Ltd.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21054524     DOI: 10.1111/j.1440-1746.2010.06568.x

Source DB:  PubMed          Journal:  J Gastroenterol Hepatol        ISSN: 0815-9319            Impact factor:   4.029


  9 in total

1.  Insulin resistance and chronic liver disease.

Authors:  Takumi Kawaguchi; Eitaro Taniguchi; Minoru Itou; Masahiro Sakata; Shuji Sumie; Michio Sata
Journal:  World J Hepatol       Date:  2011-05-27

2.  Hepatitis C virus core protein decreases lipid droplet turnover: a mechanism for core-induced steatosis.

Authors:  Charles Harris; Eva Herker; Robert V Farese; Melanie Ott
Journal:  J Biol Chem       Date:  2011-10-07       Impact factor: 5.157

3.  Hepatitis C virus induces a prediabetic state by directly impairing hepatic glucose metabolism in mice.

Authors:  Hervé Lerat; Mohamed Rabah Imache; Jacqueline Polyte; Aurore Gaudin; Marion Mercey; Flora Donati; Camille Baudesson; Martin R Higgs; Alexandre Picard; Christophe Magnan; Fabienne Foufelle; Jean-Michel Pawlotsky
Journal:  J Biol Chem       Date:  2017-05-30       Impact factor: 5.157

Review 4.  Production and pathogenicity of hepatitis C virus core gene products.

Authors:  Hui-Chun Li; Hsin-Chieh Ma; Chee-Hing Yang; Shih-Yen Lo
Journal:  World J Gastroenterol       Date:  2014-06-21       Impact factor: 5.742

5.  Lack of Association between Hepatitis C Virus core Gene Variation 70/91aa and Insulin Resistance.

Authors:  Letícia de Paula Scalioni; Allan Peres da Silva; Juliana Custódio Miguel; Márcia Paschoal do Espírito Santo; Vanessa Alves Marques; Carlos Eduardo Brandão-Mello; Cristiane Alves Villela-Nogueira; Lia Laura Lewis-Ximenez; Elisabeth Lampe; Livia Melo Villar
Journal:  Int J Mol Sci       Date:  2017-07-21       Impact factor: 5.923

6.  Frequency of Interferon-Resistance Conferring Substitutions in Amino Acid Positions 70 and 91 of Core Protein of the Russian HCV 1b Isolates Analyzed in the T-Cell Epitopic Context.

Authors:  V S Kichatova; K K Kyuregyan; N V Soboleva; A A Karlsen; O V Isaeva; M G Isaguliants; M I Mikhailov
Journal:  J Immunol Res       Date:  2018-02-07       Impact factor: 4.818

7.  Evolution of ferritin levels in hepatitis C patients treated with antivirals.

Authors:  Ming-Ling Chang; Jing-Hong Hu; Ching-Hao Yen; Kuan-Hsing Chen; Chia-Jung Kuo; Ming-Shyan Lin; Cheng-Han Lee; Shiang-Chi Chen; Rong-Nan Chien
Journal:  Sci Rep       Date:  2020-11-12       Impact factor: 4.379

8.  Independent evolution of multi-dominant viral genome species observed in a hepatitis C virus carrier.

Authors:  Tomomi Ando; Hideki Aizaki; Masaya Sugiyama; Tomoko Date; Kazuhiko Hayashi; Masatoshi Ishigami; Yoshiaki Katano; Hidemi Goto; Masashi Mizokami; Masamichi Muramatsu; Makoto Kuroda; Takaji Wakita
Journal:  Biochem Biophys Rep       Date:  2022-08-29

9.  Prevalence of amino acid mutations in hepatitis C virus core and NS5B regions among Venezuelan viral isolates and comparison with worldwide isolates.

Authors:  Rossana C Jaspe; Yoneira F Sulbarán; Maria Z Sulbarán; Carmen L Loureiro; Hector R Rangel; Flor H Pujol
Journal:  Virol J       Date:  2012-09-21       Impact factor: 4.099

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.